Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases-Reference-Cited by-同舟云学术

Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases

Published:2021-09-02 Issue:10 Volume:35 Page:
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:The FASEB Journal

Author:

Liu Chang¹,Wang Yu‐Li¹,Yang Yong‐Yu¹,Zhang Ning‐Ping²³,Niu Chen¹,Shen Xi‐Zhong²³,Wu Jian¹²³^ORCID

Affiliation:

1. MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology Department of Medical Microbiology & Parasitology School of Basic Medical Sciences Fudan University Shanghai Medical College Shanghai China

2. Department of Gastroenterology & Hepatology Zhongshan Hospital of Fudan University Shanghai China

3. Shanghai Institute of Liver Diseases Fudan University Shanghai Medical College Shanghai China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202100939R

Reference93 articles.

1. Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction

2. Fibrosis and the intestinal microbiome; a focus on chronic liver disease

3. Prevention of hepatocellular carcinoma in the Asia-Pacific region: Consensus statements

4. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases

5. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective effects and mechanism of Sangyu granule on acetaminophen-induced liver injury in mice;Journal of Ethnopharmacology;2024-09

2. Dynamic changes of gut microbiota in mouse models of metabolic dysfunction‐associated steatohepatitis and its transition to hepatocellular carcinoma;The FASEB Journal;2024-07-05

3. Therapeutic benefit of probiotic in alcohol dependence syndrome: Evidence from a tertiary care centre of India;Clinics and Research in Hepatology and Gastroenterology;2024-06

4. Microbiota and Gut–Liver Axis: An Unbreakable Bond?;Current Microbiology;2024-05-28

5. Mendelian randomization suggests a causal relationship between gut microbiota and nonalcoholic fatty liver disease in humans;Medicine;2024-03-22